196
Mon, 7/29/2019,
11:35 AM -
12:20 PM
CC-Hall C
SPEED: Biometrics and Biostatistics Part 2 — Contributed Poster Presentations
Biometrics Section , Section on Statistics in Epidemiology, Biopharmaceutical Section, Section on Bayesian Statistical Science
Chair(s): Wendy Meiring, University of California At Santa Barbara
Oral Presentations
for this session.
21:
Oversampling and Replacement Strategies in Propensity Score Matching: a Critical Review Focused on Small Samples
Daniele Bottigliengo, University of Padova ; Ileana Baldi, University of Padova; Corrado Lanera, University of Padova; Jonida Bejko, University of Brescia; Tomaso Bottio, University of Padova; Vincenzo Tarzia, University of Padova; Massimiliano Carrozzini, University of Padova; Gino Gerosa, University of Padova; Paola Berchialla, University of Torino; Dario Gregori, University of Padova
22:
A Concordance Statistic for Survival Analysis with a Censored Predictor
Kai Ding, University of Oklahoma Health Sciences Center ; Justin Dvorak, University of Oklahoma Health Sciences Center
23:
Meta-Analysis of Binary Outcomes Combining Individual Patient Data and Aggregate Data
Neha Agarwala, University of Maryland - Baltimore County ; Anindya Roy, University of Maryland - Baltimore County
24:
Multiplicity Adjustment in Clinical Trials
Michael Proschan, National Institute of Allergy and Infectious Diseases ; Erica Brittain, National Institute of Allergy and Infectious Diseases
25:
A Comparison of Stacked and Pooled Multiple Imputation
Paul Bernhardt, Villanova University
26:
Hierarchical Likelihood Approach for Joint Models of Longitudinal Non-Survival Responses and Survival Data: a Semiparametric Model with Gamma Shared Random Effects
Karl Stessy Bisselou, University of Nebraska Medical Center ; Hongying Dai, University of Nebraska Medical Center; Gleb Haynatzki, University of Nebraska Medical Center
27:
A Scalable Algorithm for Joint Modeling of Longitudinal and Competing Risks Time-To-Event Data
Shanpeng Li, UCLA Department of Biostatistics ; Eric Kawaguchi, UCLA Department of Biostatistics; Gang Li, UCLA
28:
Synthetic Data Method to Incorporate External Information into a Current Study
Tian Gu, University of Michigan ; Jeremy Taylor, University of Michigan; Bhramar Mukherjee, University of Michigan
29:
Predicting the Cross-Validated Penalty Parameter in Nodewise Lasso Regression
Mo Huang, University of Pennsylvania ; Nancy Zhang, University of Pennsylvania
30:
Statistical Assessment of Bovine Body Weight via Functional Gait Data
Andrew Raim, US Census Bureau ; Nagaraj Neerchal, University of Maryland, Baltimore County; Dan Tasch, Step Analysis LLC; Uri Tasch, Step Analysis LLC
31:
Adaptive Design with Biomarker Population Deselection and Enrichment for Oncology Trials
Pingye Zhang ; Yue Shentu, Merck & Co., Inc.; Qi Liu, Merck & Co., Inc.
32:
Unblinded Sample Size Re-Estimation for Ordinal Data
Huaihou Chen, Biogen ; Ray Zhang, Biogen; Weihua Tang, Biogen; Li Zhu, Biogen; Chunlei Ke, Biogen
34:
A Natural Lead-In Approach to Response-Adaptive Allocation
Erin Donahue, Virginia Commonwealth University ; Roy T Sabo, Virginia Commonwealth University
35:
Survival Analyzes in the Presence of Unadjudicated Events
Rakhi Kilaru, Pharmaceutical Product Development ; Andrew Montgomery Hartley, Pharmaceutical Product Development
36:
Design of a Phase 3 Trial for an Acute Treatment of a Rare Disease with Episodic Attacks
Sharon Murray
37:
Bayesian Modeling of Rare Events with Informative Censoring in Meta-Analysis
Xinyue Qi, UT MD Anderson Cancer Center ; Yucai Wang, Mayo Clinic; Chan Shen, College of Medicine, Penn State University; Michael Wang, The University of Texas MD Anderson Cancer Center; Shouhao Zhou, PennState College of Medicine
38:
Bayesian Analysis of Mixed Continuous and Time-To-Event Outcomes with Latent Variables
Xinyuan Song, The Chinese University of Hong Kong ; Deng Pan, Huazhong University of Science and Technology
39:
A Bayesian Approach with Propensity Score for Confounding Control with Case Study in Non-Medical Switch Real World Observational Studies
Zhenyi Xue, AbbVie ; Hongwei Wang, AbbVie Inc.
40:
Quantitative Decision Making (QDM) in Phase I/II Studies
Kevin Gan, GlaxoSmithKline ; Jonathan Haddad , GlaxoSmithKline
